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Abstract 23 
Study question:  What is the chance of a treatment-independent live birth following IVF 24 
(including ICSI) treatment? 25 
Summary answer:  Over five years of follow-up, the treatment-independent live birth rate 26 
was 17% in unsuccessfully treated women and 15% in those who had a live birth after IVF. 27 
What is known already:  A limited number of studies have investigated the chance of 28 
treatment-independent conception following completion of IVF, but most of them have 29 
been based on surveys with poor response rates and limited sample sizes. 30 
Study design, size, duration:  This is a population-based, retrospective cohort study of 2,133 31 
women who received IVF treatment between 1998 and 2011 at a single regional IVF Unit 32 
and were followed for a minimum of one year and maximum of 15 years after their last IVF 33 
or ICSI treatment cycle. 34 
Participants/materials, setting, methods:  This study included all women, residing in the 35 
North-East of Scotland, who attended the Aberdeen Fertility Clinic and received IVF 36 
treatment between 1998 and 2011. Clinical and diagnostic information of all women were 37 
linked with treatment and pregnancy outcome data.  A total of 2,133 women were divided 38 
into two groups:  a) those who achieved a live birth following successful IVF or ICSI 39 
treatment (n=1,060); and b) those in whom treatment was unsuccessful i.e. resulted in 40 
either no pregnancy or pregnancy loss (n=1,073). The two groups were followed from the 41 
date of the last embryo transfer until the first treatment-independent live birth or 31st 42 
December 2012, whichever came first. The primary outcome was the treatment-43 
independent live birth rate at one, two and a half, five and ten years of follow up. Cox 44 
regression was used to determine factors associated with treatment-independent live birth 45 
in each group. 46 
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Main results and the role of chance:  Within five years of follow up, the treatment-47 
independent live birth rate was 17% (95% CI, 15%-19%) among women whose IVF or ICSI 48 
treatment was unsuccessful and 15% (95% CI, 12%-17%) among women whose treatment 49 
resulted in live birth. In both groups, shorter duration of infertility, younger female age and 50 
IVF as compared to ICSI were associated with a higher chance of achieving treatment-51 
independent live birth. Among unsuccessfully treated women, the chance of post-IVF live 52 
birth was reduced in those with tubal factor infertility. Three or more previous IVF or ICSI 53 
embryo transfers were associated with a lower chance of treatment-independent live birth 54 
among successfully treated women.  55 
Limitations, reasons for caution:  The study was conducted in a single fertility centre, which 56 
could compromise the generalisability of the findings. Moreover, data were unavailable on 57 
the women’s use of contraception or active attempts to get pregnant, both of which could 58 
influence treatment-independent live birth rates.  59 
Wider implications of the findings:  This study provides a better understanding of the long-60 
term prognosis for treatment-independent live birth after completion of IVF or ICSI 61 
treatment. The results will inform women of their chances of a treatment-independent live 62 
birth following failed or successful treatment and the factors which are associated with it.  63 
Study funding/competing interest(s):  This work was funded by a Chief Scientist Office 64 
Postdoctoral Training Fellowship in Health Services Research and Health of the Public 65 
Research (Ref PDF/12/06).  The views expressed here are those of the authors and not 66 
necessarily those of the Chief Scientist Office.  The authors have no competing interests. 67 
Trial registration number: N/A  68 
Key words: IVF/ICSI outcome, treatment independent live birth, infertility, live birth rate, 69 
duration of infertility, female age  70 
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Introduction 71 
Infertility affects around one in six couples in the UK (Oakley et al. 2008). Conventional in-72 
vitro insemination (IVF), as well as intracytoplasmic sperm injection (ICSI), are the 73 
recommended treatments for women with prolonged unresolved infertility (National 74 
Institute for Health and Clinical Excellence 2013). The number of cycles and embryo 75 
transfers of IVF or ICSI treatment in the UK has increased almost three-fold over 20 years 76 
from 18,304 in 1994 to 52,288 in 2014 (Human Fertilisation and Embryology Authority 2016, 77 
Human Fertilisation and Embryology Authority 2007). While initially used to treat women 78 
with tubal disease, the scope of IVF has expanded in the last two decades to embrace a 79 
wider range of indications, including unexplained and mild male factor infertility where 80 
there is no identified barrier to pregnancy (Kamphuis et al. 2014).  81 
Although the success rate per cycle of IVF in the UK has doubled from 14% in 1994 to 82 
around 27% in 2014 (Human Fertilisation and Embryology Authority 2007, Human 83 
Fertilisation and Embryology Authority 2016), these figures show that the majority of 84 
women still do not become pregnant after their first IVF or ICSI cycle (de Mouzon et al. 85 
2010, Human Fertilisation and Embryology Authority 2016, McLernon et al. 2016). Most 86 
discontinue treatment after their first attempt due to the psychological and physical burden 87 
of treatment as well as financial constraints (Deka and Sarma 2010, Gautam 2010, Nandi et 88 
al. 2014, McLernon et al. 2016). Although women who have no absolute barrier to 89 
conception retain the ability to conceive on their own, many equate unsuccessful treatment 90 
with the end of any hope of having a baby (Throsby 2002).  91 
Few studies have reported treatment-independent live birth rates after IVF treatment and 92 
explored factors associated with them. In a recent record-linkage cohort study of women 93 
starting treatment with assisted reproductive technology (ART) and followed for up to 5 94 
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years, the rate of treatment-independent live births was 11% (Malchau et al. 2017). In a 95 
French survey, about 17% and 24% of women achieved a spontaneous pregnancy following 96 
either successful or unsuccessful IVF (Troude et al. 2012). Younger female age and shorter 97 
infertility duration have been shown to be associated with treatment-independent live birth 98 
(Shimizu et al. 1999, Hennelly et al. 2000, Osmanagaoglu et al. 2002, Brandes et al. 2010, 99 
Khalili et al. 2012, Troude et al. 2012). Women with unexplained infertility had better 100 
prognosis in comparison with those with other causes of infertility (Eijkemans et al. 2008, 101 
Donckers et al. 2011).  Many of these studies have relatively small sample sizes, a short 102 
duration of follow-up or, in the case of surveys, poor response rates (Shimizu et al. 1999, 103 
Osmanagaoglu et al. 2002, Cahill et al. 2005, Troude et al. 2016). As a result, it is difficult to 104 
determine with any degree of accuracy, the chance of a treatment-independent pregnancy 105 
or the clinical factors which affect this.  106 
We conducted a population-based cohort study to determine the incidence of women who 107 
had a treatment-independent live birth following: a) IVF or ICSI treatment which resulted in 108 
a live birth (successful group) or b) IVF or ICSI treatment which did not result in a live birth 109 
(unsuccessful group).  We also aimed to identify factors in each group that were associated 110 
with treatment-independent live birth. 111 
 112 
Methods 113 
Study population 114 
This population-based cohort study included all women residing in the North-East of 115 
Scotland who were referred to Aberdeen Fertility Clinic for investigation and subsequently 116 
received IVF (including ICSI) treatment at the Aberdeen Assisted Reproduction Unit between 117 
January 1998 and December 2011. Aberdeen Assisted Reproduction Unit is the only centre 118 
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that provides private and NHS funded IVF treatment in the North-East Scotland region 119 
(Grampian, Highlands, Orkney, and Shetland regions) (Pandey et al. 2014). 120 
The following exclusion criteria were applied: a) women aged less than 18 or over 50 at the 121 
beginning of their IVF treatment; b) women who underwent their first treatment before 122 
January 1998 or after December 2011; c) women residing in the Orkney and Shetland 123 
regions; and d) women who were treated using donor sperm, donor oocytes or surrogacy. 124 
Of the 3091 women who underwent IVF or ICSI treatment in the Aberdeen Assisted 125 
Reproduction Unit during the chosen time period, 2,133 were included in our study after 126 
applying the exclusion criteria (see Figure 1). 127 
 128 
Study groups and follow up 129 
The cohort of 2,133 women were divided into two groups: a “successfully treated group” of 130 
1,060 women who had a live birth resulting from IVF treatment and an “unsuccessfully 131 
treated group” of 1,073 women whose treatment did not result in a live birth. Women in 132 
the first group were followed from treatment-dependent live birth until: treatment-133 
independent live birth, they returned to the clinic with a different male partner or 31st 134 
December 2012, whichever came first. Women in the second group were followed from the 135 
first menstrual cycle after unsuccessful IVF treatment until: treatment-independent live 136 
birth, they returned to the clinic with a different male partner or 31st December 2012, 137 
whichever came first. 138 
 139 
Databases 140 
Aberdeen Fertility Centre database holds registration and demographic data of all infertile 141 
women referred to the Aberdeen Assisted Reproduction Unit (Pandey et al. 2014). The 142 
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Assisted Reproduction Unit database, which contains treatment details, was record-linked 143 
to the Aberdeen Fertility Centre database (Maheshwari et al. 2009).  Diagnostic and 144 
treatment data from both databases were also record-linked to the national Scottish 145 
maternity admission database (SMR02). SMR02 stores maternity admission records which 146 
provided the pregnancy outcomes for women in this study (Administrative Data Liaison 147 
Service 2017). Live birth data was available until December 2012 meaning that all women 148 
were followed for at least one year after their last embryo transfer. The final linked 149 
anonymised data was stored on the dedicated secure Data Safe Haven (DaSH) University of 150 
Aberdeen server with access restricted to named and approved researchers only.  151 
 152 
Baseline characteristics  153 
Baseline characteristics of women at treatment dependent live birth (for the successful 154 
group) or after their final IVF cycle (for the unsuccessful group) included female age (years), 155 
the cause of infertility (categorised as male factor, unexplained infertility, tubal factor, 156 
ovulatory disorder, more than one cause or other), number of fresh or frozen embryo 157 
transfers conducted, duration of infertility (years), infertility type (primary versus secondary) 158 
and treatment type (IVF or ICSI). 159 
 160 
Outcome 161 
The primary outcome was the treatment-independent live birth rate at one, two and a half, 162 
five and ten years of follow up. The final linked dataset enabled us to identify all treatment-163 
dependent and treatment-independent live births from the same woman. Gestational age 164 
at birth, which was recorded in the national Scottish maternity admission database 165 
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(SMR02), was used to identify and code live births as treatment independent or treatment 166 
dependent by comparing the estimated pregnancy dates to dates of embryo transfer. 167 
 168 
Statistical analysis 169 
Descriptive statistics of women and treatment characteristics were calculated at the time of 170 
treatment-dependent live birth (successful group) or after the last IVF cycle (unsuccessful 171 
group). The frequency and percentage were used for categorical data and means and 172 
standard deviations for normally distributed data. For skewed data, median and the 25th 173 
and 75th percentiles were presented. 174 
 175 
Treatment independent live birth 176 
We estimated the treatment independent live birth rate at one, two and a half, five and ten 177 
years of follow up in both the “successful” and “unsuccessful” groups by fitting a Kaplan-178 
Meier curve for time to pregnancy and calculated the median follow up in both groups. 179 
 180 
Factors associated with treatment independent live birth 181 
A multivariable Cox regression model was used per “successful” and “unsuccessful” group to 182 
examine the association between baseline characteristics and time-to-treatment-183 
independent live birth. In addition to the baseline characteristics, the year of IVF treatment 184 
was included to account for changes in policy and practice.  185 
A backward stepwise selection technique was used with a decrease in Akaike’s Information 186 
Criterion (AIC) when a variable was removed representing a better fit (Akaike, 1974). 187 
Statistical software IBM SPSS statistics version 24 was used for data management and R 188 
3.4.3 was used for data analysis. 189 
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 190 
Missing data 191 
Approximately 3% of data on patient and/or treatment characteristics was missing. We 192 
applied single imputation to account for this, including all mentioned baseline 193 
characteristics and the cumulative hazard for pregnancy in the imputation model to account 194 
for the time aspect in the data (White and Royston, 2009). 195 
 196 
Ethical approval 197 
The study was approved by the North of Scotland Research Ethics Committee (12/NS/0120). 198 
Consent was not required from study participants as the final database did not contain 199 
identifiable information. 200 
 201 
Results 202 
Characteristics of the study population 203 
Clinical characteristics of all women at the time of their last IVF cycle (unsuccessful group) or 204 
after giving birth (successful group) are presented in Table I. Women whose treatment was 205 
unsuccessful were older (mean of 35.7 versus 33.9 years) compared to women whose IVF 206 
treatment was successful. The cause of infertility, number of embryo transfers and duration 207 
of infertility (median of 5.1 years for the successful group and 5.3 years for the unsuccessful 208 
group) were comparable across the two groups. 209 
 210 
Treatment-independent live birth 211 
Of the 1,073 unsuccessfully treated women, 185 had at least one subsequent treatment-212 
independent live birth over the maximum follow-up period of 15 years (Figure 2). The 213 
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median follow-up period was 6 years (2.16-10.5). Of the 1,060 successfully treated women, 214 
151 had at least one treatment-independent live birth over the maximum follow-up period 215 
of 15 years (Figure 2). The median follow-up time was 5.9 years (2.6-10). 216 
The one-year Kaplan-Meier treatment-independent live birth rate was 10% (95% CI, 8%-217 
12%) among unsuccessfully treated women and 4% (95% CI, 3%-5%) among successfully 218 
treated women (Figure 3). At two and a half years, these rates increased to 15% (95% CI, 219 
12%-17%) and 11% (95% CI, 9%-13%) respectively. The five-year rates were 17% (95% CI, 220 
15%-19%) and 15% (95% CI, 12%-17%), and the ten-year rates were 19% (95% CI, 16%-22%) 221 
and 17% (95% CI, 14%-19%), respectively.  222 
 223 
Predictive factors 224 
Factors associated with a treatment-independent live birth among successfully treated 225 
women are shown in Table II as hazard ratios (HR) and 95% confidence intervals (CIs). The 226 
multivariable analysis showed that the factors of an increased female age, increased 227 
duration of infertility, two or three or more embryo transfers compared to one embryo 228 
transfer and ICSI versus IVF treatment (HR: 0.62, 95%CI 0.44 to 0.88) were all associated 229 
with a decrease in the chance of treatment-independent pregnancy.   230 
Factors associated with a treatment-independent live birth among unsuccessfully treated 231 
women are shown in Table III. The factors of an increased female age, increased duration of 232 
infertility and ICSI versus IVF treatment (HR: 0.70, 95%CI 0.47 to 1.05) were associated with 233 
a decrease in the chance of pregnancy. The cause of infertility was associated with the 234 
chance of pregnancy with tubal factor having the worst prognosis (HR: 0.31. 95%CI 0.17 to 235 
0.55) and ovulatory disorder having the best prognosis (HR: 1.11, 95%CI 0.64 to 1.94) 236 
compared to male factor infertility as reference.  237 
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 238 
Discussion  239 
Principal findings 240 
Following unsuccessful IVF or ICSI treatment, approximately 15% (one in seven) women had 241 
a treatment-independent pregnancy leading to live birth over two and a half years, rising to 242 
17% (one in six) over five years. The corresponding figures in women who had an IVF or ICSI 243 
live birth were slightly lower at 11% (one in nine) and 15% (one in seven) respectively. After 244 
ten years, the percentage is very little more than that at five years. The Kaplan-Meier curve 245 
indicated that for the group in which IVF was successful, the time to treatment independent 246 
live birth was longer compared to women who were unsuccessful. This difference could be 247 
explained by the fact that women who had the desired child through fertility treatment may 248 
be less likely to try to get pregnant again soon after having a live birth and may have used 249 
contraception for a period of time (Troude et al. 2012). 250 
Increasing female age and duration of infertility were associated with a decreased chance of 251 
treatment-independent live birth in both groups. Having more than one embryo transfer 252 
and having received ICSI instead of IVF treatment lowered the chance of a treatment-253 
independent live birth among successfully treated women. Among unsuccessfully treated 254 
women, the chance of post-IVF live birth was reduced in those with tubal factor infertility 255 
and those who received ICSI treatment. 256 
 257 
Strengths and limitations  258 
At 2,133, the sample size for this population-based retrospective cohort study was 259 
reasonably large compared to most studies which have examined treatment-independent 260 
live birth after IVF and the follow up was long (Shimizu et al. 1999, Hennelly et al. 2000, 261 
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Osmanagaoglu et al. 2002, Cahill et al. 2005, Ludwig et al. 2008, Donckers et al. 2011, Khalili 262 
et al. 2012, Pandey et al. 2014). Our sample is representative of the entire population as 263 
there is only one IVF clinic in the region. Data used in this record-linkage study were 264 
extracted from high quality and validated databases that have been successfully used in 265 
previous studies (Maheshwari et al. 2009, Pandey et al. 2014, Rukuni et al. 2016). A further 266 
strength of this study was the fact that our study was not reliant on telephone interviews or 267 
postal questionnaires, minimising recall bias and overcoming problems relating to poor 268 
response rates reported in some earlier studies (Shimizu et al. 1999, Hennelly et al. 2000, 269 
Osmanagaoglu et al. 2002, Cahill et al. 2005, Khalili et al. 2012). Our population-based study 270 
design allowed us to avoid the situation reported in a Danish study (Pinborg et al. 2009) 271 
where non-response by women who failed to become pregnant led to overestimation of the 272 
treatment-independent live birth rate by 5.3%.  273 
The study has a number of limitations. A key drawback is the single-centre retrospective 274 
design, which raises questions about generalisability. Although the majority of fertility clinics 275 
in the UK have access to the same guidelines (NICE guidelines), the selection of candidates 276 
and number of cycles could have been influenced by clinical judgment and patient 277 
preferences (Kim et al. 2015). In addition, a multicentre study design with a higher number 278 
of participants would have increased the sample size in the different subgroups which 279 
would have allowed us to draw more accurate comparisons between causes of infertility.  280 
Another factor which could limit the generalisability of our study to other populations is that 281 
the population of the North East of Scotland is ethnically relatively homogeneous; the 282 
majority of residents are Caucasians (Scottish Gov 2014). 283 
 A natural drawback associated with data from clinical databases is the fact that not all 284 
desired covariates were available. For instance, data were unavailable on use of 285 
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contraception or active plans to get pregnant. A questionnaire-based study found that 286 
10.9% of women following ICSI treatment had used contraception (Ludwig et al. 2008). 287 
Exclusion of women who used active contraception following IVF, leaving a cohort of 288 
women who remained actively trying for a second baby, might increase the proportion of 289 
treatment-independent live births over the observation period. It is difficult to define a 290 
timepoint such as the ‘completion of IVF treatment’ with certainty as we were unable to 291 
distinguish between a treatment-independent conception that occurred between planned 292 
IVF cycles and a conception that occurred after the couple decided not to have further IVF. 293 
In addition, we lacked information on any pregnancy outcomes which may have occurred 294 
outside Scotland and any IVF treatments which may have occurred outside the Grampian 295 
region. It is possible that some women could have undergone treatment outside the region 296 
and then returned to give birth. This would have been counted as a natural conception using 297 
our databases. Finally, although we censored women if they came back with a different 298 
partner during treatment cycles, we were not able to detect a change in partnership after 299 
IVF treatment. We were also unable to account for dropout factors such as stress due to 300 
failed IVF treatment. 301 
 302 
Related literature  303 
Our treatment-independent live birth rate of 17% (one in six) over five years in 304 
unsuccessfully treated women was higher than the 11.5% reported in a five-year follow-up 305 
study in Belgium (Osmanagaoglu et al. 2002), 10% in a five-year cohort study in  the 306 
Netherlands (Brandes et al 2010), and the 12% observed by Troude et al (2016) in a French 307 
cohort followed up for  eight years. However, Troude et al (2012) reported a treatment 308 
independent live birth rate of 24% among women unsuccessfully treated by IVF over an 309 
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average follow-up period of seven years which was longer than our median follow-up period 310 
(Troude et al. 2012). Approximately 15% of successfully treated women in our study had a 311 
treatment-independent live birth over five years. This figure is slightly lower than the 17% to 312 
21% reported in the literature from France, Ireland and Japan (Shimizu et al. 1999, Hennelly 313 
et al 2010, Troude et al. 2012) but higher than the 11.7% observed in a five-year follow-up 314 
Danish study (Pinborg et al. 2009).  315 
Recent publications have reported higher rates of treatment-independent live birth after IVF 316 
treatment compared to older studies (Shimizu et al. 1999, Hennelly et al 2010, Troude et al. 317 
2012). This is despite the increase in success rate of IVF treatment over the last few years 318 
(Human Fertilisation and Embryology Authority 2007, Human Fertilisation and Embryology 319 
Authority 2016). Increased availability of IVF and early access for women who have a 320 
reasonably good chance of spontaneous pregnancy has been noted to lead to 321 
overtreatment (Kamphuis et al. 2014, Marcus et al. 2016). A Danish study found that 9.1% of 322 
patients on the waiting list for IVF had a treatment-independent live birth within one year 323 
(Eijkemans et al. 2008). The median IVF cycle number in our study was two for 324 
unsuccessfully treated women which was higher than the average number in the UK 325 
(McLernon et al. 2016). This is probably due to the fact that during the study period, the 326 
Scottish Government supported up to two complete cycles of IVF (before increasing it to 327 
three rounds in 2017) (Fertility Fairness 2017). 328 
Our study showed that the chance of having a treatment-independent live birth among both 329 
successfully and unsuccessfully treated women decreased with increasing female age and 330 
duration of infertility. Both of these factors have been identified as being associated with 331 
treatment-independent live birth in previous studies (de La Rochebrochard et al. 2009, 332 
Khalili et al. 2012, Walschaerts et al. 2012, Troude et al. 2016).  In successfully treated 333 
15 
 
 
 
women, we observed a lower chance of treatment independent live birth in women who 334 
received more than one cycle, in particular in women who received three cycles (or more), a 335 
finding also previously demonstrated in a Danish prospective cohort study (Pinborg et al., 336 
2009). 337 
In those who had unsuccessful IVF, women with ovulatory disorder had an increased chance 338 
of treatment-independent live birth whilst those with tubal factor infertility had a decreased 339 
chance of treatment-independent live birth. This has been previously reported in a 340 
prospective cohort study (Donckers et al, 2011) and is indicative of sporadic ovulation in 341 
women with this diagnosis. ICSI was associated with a decreased chance of treatment-342 
independent live birth for both the successful and unsuccessful groups even after 343 
accounting for cause of infertility. This finding could be due to the clinician choosing ICSI for 344 
couples who have a relatively poor prognosis based on predictors unknown to us. 345 
 346 
Wider implications of the findings 347 
This study provides a better understanding of the long-term prognosis of treatment-348 
independent live birth and associated factors of such an outcome. The results can provide 349 
an indication to women, who remain childless after fertility treatment or who wish to have 350 
another baby after successful IVF treatment, of their prognosis based on their 351 
characteristics. Those counselling infertile women should include information about their 352 
chance of natural conception at the end of fertility treatment, which starts to peak in the 353 
first few years. 354 
 355 
Conclusion 356 
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We found that treatment-independent live birth after either successful or failed IVF or ICSI 357 
treatment occurs in approximately one in six couples. This is more likely to occur in younger 358 
women treated with IVF and who have been trying to conceive for a relatively short 359 
duration. Our results will help clinicians to counsel infertile couples on the characteristics 360 
associated with a live birth after a failed or successful IVF outcome. 361 
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Table 1 Characteristics of the women after treatment dependent live birth (successfully treated 540 
group) or after their last IVF cycle (unsuccessfully treated group) 541 
 542 
 543 
Characteristics 
Successfully 
treated group 
n = 1060 
Unsuccessfully 
treated group 
n = 1073 
Mean (SD) female age (years)  33.9 (4.0) 35.7 (4.7) 
Infertility type (primary versus secondary), n (%) 0 (0) 663 (61.8) 
Cause of infertility, n (%)   
    Male 383 (36.1) 329 (30.7)) 
    Ovulatory 70 (6.6) 85 (7.9) 
    Unexplained 284 (26.8) 259 (24.1) 
    Tubal  179 (16.9) 228 (21.1) 
    Other/unknown  41 (3.9) 59 (5.5) 
    More than one cause  103 (9.7) 113 (10.5) 
Infertility duration (median, 25th-75th) 5.1 (3.9-6.7) 5.3 (3.7-7.2) 
Infertility duration, n (%)   
    <3 99 (9.3) 140 (13.0) 
    3-6 607 (57.3) 512 (47.7) 
    >6 354 (33.4) 421 (39.2) 
No. of embryo transfer episodes(median, 25th-75th) 2 (1-3) 2 (1-3) 
No. of embryo transfer episodes, n (%)   
    1 398 (37.5) 398 (37.1) 
    2 261 (24.3) 277 (25.8) 
    3 172 (16.0) 181 (16.9) 
    >3 229 (21.3) 217 (20.2) 
Treatment type   
    IVF ( in vitro fertilization) 652 (61.5) 708 (65.4) 
    ICSI (intracytoplasmic sperm injection) 408 (38.5) 371 (34.6) 
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Table 2 Factors associated with treatment independent live birth over time in successfully treated 544 
women (n=1060) 545 
 Multivariable analysis with backward 
selection based on AIC 
HR 95% CI P value 
Female age (per year ≤31)  0.92  0.84 to 1.01 0.10 
Female age (per year >31)  0.89  0.77 to 1.02 0.09 
Duration of infertility (per year) 0.89 0.83 to 0.97 0.006 
Number of embryo transfer episodes    
       1 a 1   
       2 0.74 0.51 to 1.09 0.13 
       3 0.31 0.17 to 0.59 <0.001 
       >3 0.52 0.32 to 0.84 0.007 
Type of treatment    
       IVF a 1   
ICSI 0.62 0.44 to 0.88 0.007 
    
a Used as a reference variable. 546 
HR = hazard ratio; CI = confidence interval; BMI = body mass index; IVF = in vitro fertilisation; ICSI = 547 
intracytoplasmic sperm injection 548 
Note: Female age was included in the model as two continuous linear terms, one for age up to 31 549 
and one for age over 31 years 550 
  551 
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Table 3 Factors associated with treatment independent live birth over time in unsuccessfully 552 
treated women (n=1073) 553 
 Multivariable analysis with backward selection 
based on AIC 
HR 95% CI P value 
Female age (per year ≤31)  1.04  0.94 to 1.15 0.48 
Female age (per year >31)  0.85  0.74 to 0.97 0.02 
Duration of infertility (per year) 0.86 0.81 to 0.92 <0.001 
Cause of infertility    
Male a 1   
Anovulation 1.11 0.64 to 1.94 0.71 
Unexplained 1.08 0.70 to 1.67 0.74 
Tubal 0.31 0.17 to 0.55 <0.001 
Other 0.61 0.30 to 1.22 0.16 
More than one cause 0.48 0.26 to 0.87 0.02 
Type of treatment    
       IVF a 1   
       ICSI 0.70 0.47 to 1.05 0.08 
    
a Used as a reference category. 554 
HR = hazard ratio; CI = confidence interval; BMI = body mass index; IVF = in vitro fertilisation; ICSI = 555 
intracytoplasmic sperm injection 556 
Note: Female age was included in the model as two continuous linear terms, one for age up to 31 557 
and one for age over 31 years 558 
 559 
 560 
 561 
 562 
 563 
 564 
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Figure 1 Flow chart showing inclusion and exclusions before data analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Initial population 
Women registered for IVF 
treatment at AFC between 1992 
and 2014 
(3091 women) 
 
Incomplete records (missing 
dates of treatment cycles or 
no data about treatment 
outcome) 
(113 women) 
  Women who started IVF 
prior to 1998 or after 2011 
 (283 women) 
 
Women residing in the 
Orkney and Shetland regions  
(6 women) 
  
Women who at their first 
treatment were under 18 
years old or over 50 years old 
(6 women) 
 
  Women who were treated 
with only intrauterine 
insemination or who were 
treated with donor 
insemination, donor 
oocytes or surrogacy 
 (496 women) 
 
Included in the study 
(2133 women) 
  
Women who did not 
provide consent for use 
of treatment data 
(54 women) 
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Figure 2 Flow chart showing the number of women per group and resulting treatment independent live births over the maximum follow-up period of 15 
years 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2133 women received IVF treatment 
(1998 to 2011)  
1073 unsuccessfully 
treated women 
 
151 women (14.2%) 
had natural 
conception leading to 
live birth 
 
909 women (85.8%) 
had no natural 
conception leading to 
live birth 
 
1060 successfully 
treated women  
 
  185 women (17.2%) 
had natural 
conception leading 
to live birth 
 
888 women (82.8%) 
had no natural 
conception leading 
to live birth 
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